Performance of plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid-PET status in a DPUK-KOREAN cohort

Background: We assessed the feasibility of plasma Aβ42/Aβ40 determined using a novel liquid chromatography-mass spectrometry method (LC-MS) as a useful biomarker of PET status in a Korean cohort from the DPUK Study. Methods:<...

Full description

Bibliographic Details
Main Authors:	Jang, H, Kim, C-H, Seo, SW, Na, D, Gallagher, J
Format:	Journal article
Language:	English
Published:	BioMed Central 2021

Similar Items

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
by: Julie K. Wisch, et al.
Published: (2023-01-01)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
by: Michelle R. Campbell, et al.
Published: (2021-01-01)

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment
by: Darren M. Weber, et al.
Published: (2024-03-01)

Quantitative Analysis of Eight Compounds in Traditional Korean Medicine, Gongjindan Using HPLC, UPLC–MS/MS, and GC–MS/MS Systems
by: Chang-Seob Seo, et al.
Published: (2023-03-01)

Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
by: Sánchez, L, et al.
Published: (2011)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
by: Hans-Wolfgang Klafki, et al.
Published: (2022-12-01)

Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
by: Karolina Wilczyńska, et al.
Published: (2020-10-01)

Aggregation states of Aβ1-40, Aβ1-42 and Aβp3-42 amyloid beta peptides: a SANS study
by: Festa, Giulia, et al.
Published: (2020)

Revisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries
by: Orkid Coşkuner-Weber
Published: (2018-08-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
by: Jung-Min Pyun, et al.
Published: (2024-02-01)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
by: Vasilios C. Constantinides, et al.
Published: (2023-02-01)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
by: Piotr Lewczuk, et al.
Published: (2021-12-01)

Correlation of Plasmatic Amyloid Beta Peptides (Aβ-40, Aβ-42) with Myocardial Injury and Inflammatory Biomarkers in Acute Coronary Syndrome
by: Luis Eduardo Del Moral, et al.
Published: (2024-02-01)

Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides
by: Li Wang, et al.
Published: (2021-01-01)

Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
by: Daniel J. Figdore, et al.
Published: (2024-01-01)

Influence of denaturants on amyloid β42 aggregation kinetics
by: Tanja Weiffert, et al.
Published: (2022-09-01)

HPLC–PDA and LC–MS/MS Analysis for the Simultaneous Quantification of the 14 Marker Components in Sojadodamgangki-Tang
by: Chang-Seob Seo, et al.
Published: (2020-04-01)

secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids
by: Lorena De Mena, et al.
Published: (2017-07-01)

Impact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia
by: Xiaoyue Zhu, et al.
Published: (2022-11-01)

Aβ42/Aβ40 and Aβ42/Aβ38 ratios are associated with measures of gait variability and activities of daily living in mild Alzheimer's disease: a pilot study
by: Koychev, I, et al.
Published: (2018)

Simultaneous Analysis of Bergapten and Schinifoline in Zanthoxylum schinifolium Seeds Using HPLC and UPLC-MS/MS Systems
by: Chang-Seob Seo
Published: (2023-03-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia
by: Lise Colmant, et al.
Published: (2024-01-01)

New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding
by: Anna I. Sulatskaya, et al.
Published: (2022-05-01)

HPLC-MS/MS Analysis for Sphingosine 1-Phosphate after the Dephosphorylation by Hydrogen Fluoride
by: Hee-Jung Kim, et al.
Published: (2024-01-01)

In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
by: Ann Tiiman, et al.
Published: (2015-09-01)

Comparative Studies of Disordered Proteins with Similar Sequences: Application to Aβ40 and Aβ42
by: Fisher, Charles K., et al.
Published: (2014)

Hyper-glycemia and insulinemia induce morphological changes and modulate secretion of S100B, S100A8, amyloid β 1–40 and amyloid β 1–42, in a model of human dopaminergic neurons
by: A. Kubis-Kubiak, et al.
Published: (2022-12-01)

Copper(II) Can Kinetically Trap Arctic and Italian Amyloid‑β40 as Toxic Oligomers, Mimicking Cu(II) Binding to Wild-Type Amyloid‑β42: Implications for Familial Alzheimer’s Disease
by: Yao Tian, et al.
Published: (2024-02-01)

The Position of Aβ22-40 and Aβ1-42 in Anionic Lipid Membranes Containing Cholesterol
by: Matthew A. Barrett, et al.
Published: (2015-11-01)

Presenilin 1 deficiency impairs Aβ42-to-Aβ40- and angiotensin-converting activities of ACE
by: Yuan Gao, et al.
Published: (2023-02-01)

Phase II Metabolism of Asarone Isomers In Vitro and in Humans Using HPLC-MS/MS and HPLC-qToF/MS
by: Lena Hermes, et al.
Published: (2021-08-01)

Method Development and Validation for Simultaneous Analysis of Eleven Components for Quality Control of Geumgwesingihwan Using HPLC–DAD and UPLC–MS/MS
by: Chang-Seob Seo, et al.
Published: (2022-08-01)

Obstructive sleep apnea and amyloid-β42 in adolescents: The results of a pilot study
by: O. N. Berdina, et al.
Published: (2022-07-01)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
by: Terrone L. Rosenberry, et al.
Published: (2022-12-01)

Discovery of a biomarker for β-Thalassemia by HPLC-MS and improvement from Proton Transfer Reaction – Parallel Ion Parking
by: Yuan Lin, et al.
Published: (2023-04-01)

Dementias Platform UK (DPUK) Portal
by: Simon Thompson
Published: (2017-04-01)

Effect of Ovocystatin on Amyloid β 1-42 Aggregation—In Vitro Studies
by: Bartłomiej Stańczykiewicz, et al.
Published: (2023-03-01)

Differential effects of NSAIDs on amyloid β1-42 peptide aggregation
by: Atheer Al-Zurfi, et al.
Published: (2019-05-01)